McDonnell Boehnen Hulbert & Berghoff LLP partner Dr. Kevin E. Noonan is quoted in an April 12, 2013 Bloomberg.com article entitled, “Biotech Industry at Stake in Human Gene Patent Decision.” The U.S. Supreme Court next week will debate whether human genes can be patented, hearing arguments from doctors, patients and scientists who say patents are stifling clinical testing and research. The case is Association for Molecular Pathology v. Myriad Genetics, 12-398. View the article